Lessons on Honoraria and Research Grants From the Alexion Settlement

Wednesday, July 22, 2020

Martin Bloor was quoted in Anti-Corruption Report discussing the settlement agreement that Boston-based Alexion Pharmaceuticals reached with the SEC to settle FCPA charges over inappropriate payments to health care providers in Russia and to government officials in Turkey. Commenting on the settlement, Martin said that the “SEC continues to move cases along despite the global pandemic and shutdown.”

To read more of this article, click here. (subscription required)


Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.